Comparison of mRNA-1273 and BNT162b2 Vaccines on Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Death During the Delta-Predominant Period.

Wang, Lindsey; Davis, Pamela B; Kaelber, David C; Volkow, Nora D; Xu, Rong

Wang, Lindsey; Davis, Pamela B; Kaelber, David C; Volkow, Nora D; Xu, Rong.

Wang L; Center for Artificial Intelligence in Drug Discovery, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Davis PB; Center for Community Health Integration, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Kaelber DC; Center for Clinical Informatics Research and Education, MetroHealth System, Cleveland, Ohio.
Volkow ND; National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland.
Xu R; Center for Artificial Intelligence in Drug Discovery, Case Western Reserve University School of Medicine, Cleveland, Ohio.

JAMA ; 327(7): 678-680, 2022 02 15.

Article in English | MEDLINE | ID: covidwho-1718163

Subject(s)

2019-nCoV Vaccine mRNA-1273; BNT162 Vaccine; COVID-19/epidemiology; SARS-CoV-2; Adult; Aged; COVID-19/mortality; COVID-19/prevention & control; COVID-19/virology; COVID-19 Vaccines; Female; Hospitalization/statistics & numerical data; Humans; Male; Middle Aged; Survival Analysis; United States/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 / BNT162 Vaccine / 2019-nCoV Vaccine mRNA-1273 Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: North America Language: English Journal: JAMA Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google